Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Journal of Cataract and Refractive Surgery|August 23, 2011
Cupid fixation for repositioning subluxated intraocular lensManuel Domingues, Pedro Brito, Manuel Falcão, et al.
Acta Medica Portuguesa|July 15, 2020
SARS-COV-2 in Ophthalmology: Current Evidence and Standards for Clinical PracticeSónia Torres-Costa, Mário Lima-Fontes, Fernando Falcão-Reis, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 12, 2020
532-nm Subthreshold Micropulse Laser for the Treatment of Chronic Central Serous RetinopathyKeissy Sousa, Gil Calvão-Santos, Marina João, et al.
Survey of Ophthalmology|November 29, 2021
Gut microbiota and age-related macular degeneration: A growing partnershipMário Lima-Fontes, Luís Meira, Pedro Barata, et al.
Acta Ophthalmologica|August 23, 2008
Multiple effects of bevacizumab in angiogenesis: implications for its use in age-related macular degenerationAngela Carneiro, Manuel Falcão, Isabel Azevedo, et al.
Revista De Saude Publica|June 4, 2015
Factors associated with vaccination coverage in children < 5 years in AngolaManuel Falcão Saturnino de Oliveira, Edson Zangiacomi Martinez, Juan Stuardo Yazlle Rocha
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2020
Cytokines and Growth Factors as Predictors of Response to Medical Treatment in Diabetic Macular EdemaSónia Torres-Costa, Maria Carolina Alves Valente, Fernando Falcão-Reis, et al.
Case Reports in Ophthalmology|November 2, 2023
Two-Step Iridocorneal Endothelial Syndrome Management: Endocapsular Intraocular Lens and Artificial Iris Followed by Descemet's Stripping Automated Endothelial KeratoplastyJoão Pinheiro-Costa, Inês Coelho-Costa, Fernando Falcão-Reis, et al.
Journal of Ophthalmology|November 19, 2019
Outer Nuclear Layer as the Main Predictor to Anatomic Response to Half Dose Photodynamic Therapy in Chronic Central Serous RetinopathyKeissy Sousa, Ana Rita Viana, Joana Pires, et al.
Experimental Eye Research|January 13, 2009
Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cellsAngela Carneiro, Manuel Falcão, Ana Pirraco, et al.
Pageof 8